BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2709373)

  • 1. Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
    Jacobson KA; Barone S; Kammula U; Stiles GL
    J Med Chem; 1989 May; 32(5):1043-51. PubMed ID: 2709373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
    Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
    Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.
    Stiles GL; Jacobson KA
    Mol Pharmacol; 1988 Dec; 34(6):724-8. PubMed ID: 3200248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.
    Dennis D; Jacobson K; Belardinelli L
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H661-71. PubMed ID: 1558173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
    Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
    J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.
    Jacobson KA; de la Cruz R; Schulick R; Kiriasis L; Padgett W; Pfleiderer W; Kirk KL; Neumeyer JL; Daly JW
    Biochem Pharmacol; 1988 Oct; 37(19):3653-61. PubMed ID: 3178879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functionalized congener approach to adenosine receptor antagonists: amino acid conjugates of 1,3-dipropylxanthine.
    Jacobson KA; Kirk KL; Padgett WL; Daly JW
    Mol Pharmacol; 1986 Feb; 29(2):126-33. PubMed ID: 3005825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
    Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
    J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.
    Jacobson KA; Ukena D; Kirk KL; Daly JW
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4089-93. PubMed ID: 3012550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
    J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors.
    Ukena D; Jacobson KA; Padgett WL; Ayala C; Shamim MT; Kirk KL; Olsson RO; Daly JW
    FEBS Lett; 1986 Dec; 209(1):122-8. PubMed ID: 3803571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
    Daly JW; Padgett WL; Shamim MT
    J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists.
    Schneller SW; Ibay AC; Christ WJ; Bruns RF
    J Med Chem; 1989 Oct; 32(10):2247-54. PubMed ID: 2795597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U; Ukena D; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells.
    Ukena D; Daly JW; Kirk KL; Jacobson KA
    Life Sci; 1986 Mar; 38(9):797-807. PubMed ID: 3005794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
    J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA; Johnson RA; Wells JN
    Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the adenosine receptor with adenosine and xanthine biotin conjugates.
    Jacobson KA; Kirk KL; Padgett W; Daly JW
    FEBS Lett; 1985 May; 184(1):30-5. PubMed ID: 2985445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
    Kim SA; Marshall MA; Melman N; Kim HS; Müller CE; Linden J; Jacobson KA
    J Med Chem; 2002 May; 45(11):2131-8. PubMed ID: 12014951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.